Chapter 78: Peptic Ulcer Disease and Gastritis Flashcards

1
Q

It protect mucosa by enhancing mucus and bicarbonate production and by enhancing mucosal blood flow, thereby supporting metabolism

A

Prostagladin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Thought to be the causal agents of peptic ulcer disease in most cases

A

NSAIDS and H. pylori

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Characteristic of H. pylori

A

Spiral, gram-negative, urease-producing, flagellated bacterium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Continuous or recurrent upper abdominal pain or discomfort and may be caused by a number of diseases or may be functional

A

Dyspepsia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

The most classic symptom of peptic ulcer disease

A

Burning epigastric pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

The most common presentation of gastritis is ____

A

The most common presentation of gastritis is GI bleeding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

The gold standard for diagnosis of peptic ulcer disease is ____

A

The gold standard for diagnosis of peptic ulcer disease is visualization of an ulcer by upper GI endoscopy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Laboratory test that can be used to determine the presence of infection after eradication therapy

A

Urea breath test

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Accurate time to do urea breath test after H. pylori eradication

A

Testing performed ≥4 weeks after completion of H. pylori eradication therapy is useful as a test of cure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

When to do testing for H. pylori?

A

after 2-4 weeks of medications

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Current literature supports using ____ as first-line noneradication therapy for peptic ulcers

A

Current literature supports using proton pump inhibitors as first-line noneradication therapy for peptic ulcers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Long term side effect of proton pump inhibitors

A

Clostridium difficile–associated diarrhea, fracture, pneumonia risk, chronic kidney disease, and hypomagnesemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

True or False

In H2 receptor antagonists, because of renal excretion, make dosage adjustments in patients with renal failure

A

True

In H2 receptor antagonists, because of renal excretion, make dosage adjustments in patients with renal failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

This H2 receptor antagonist has the most significant drug interactions due to inhibition of cytochrome P450 activity

A

Cimetidine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Drug that appears to protect the ulcer from acid exposure by forming a sticky gel that adheres to the ulcer crater but does not relieve pain

A

Sucralfate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Drug that heal ulcers by buffering gastric acid

A

Antacids

17
Q

Component of Antacids that may accumulate and cause osteoporosis, encephalopathy and hypermagnesemia

A

Aluminum in renal failure

18
Q

Drug that may prevent ulcer formation in those concurrently receiving NSAID therapy

A

Misoprostol

19
Q

Component of triple therapy in eradication of H. pylori

A

proton pump inhibitor, clarithromycin, and either amoxicillin or metronidazole

20
Q

Most common cause of GI-related hospital admissions

A

Upper GI bleeding

21
Q

It is given 30 minutes prior to endoscopy to improve visualization of the gastric mucosa

A

Azithromycin IV

22
Q

It is use for classification of lesion to predict risk of rebleeding

A

Forrest classification

23
Q

Forrest classification

A

Active spurting of blood (Ia); Active oozing (Ib); Nonbleeding visible vessel (IIa); Adherent clot (IIb); Flat pigmented spot (IIc); and An ulcer with a clean base (III)

24
Q

“Alarm Features” for Endoscopy

A
  • Age >50 y, with new-onset symptoms
  • Unexplained weight loss
  • Persistent vomiting
  • Dysphagia or odynophagia
  • Iron deficiency anemia or GI bleeding
  • Abdominal mass or lymphadenopathy
  • Family history of upper GI malignancy